XIG: FHIR Resources

FHIR IG Statistics: FHIR Resources

Version: All | R2 | R2B | R3 | R4 | R4B | R5 | R6
Authority: All | hl7 | ihe | national
Realm: All | BNW | au | be | br | ca | ch | cl | cr | cz | de | dk | ee | eu | fi | fr | il | in | it | jp | nl | no | nz | pt | se | sl | stt | tw | uk | us | uv | vn
View: All | Resource Profiles | Datatype Profiles | Extensions | Logical Models | CodeSystems | ValueSets | ConceptMaps

Resources - All Kinds, Realm US, Authority Hl7

16,400 resources

By Version

R2: 0
R2B: 0
R3: 524
R4: 15,438
R4B: 0
R5: 438
R6: 0

Start Prev Rows 11000 - 11200 Next

Package	Version	Identity	Name/Title	Status	Date
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.105.12.1007	Major Depression	active	2017-05
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.105.12.1104	Schizophrenia or Psychotic Disorder	active	2024-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.105.12.1203	Mental Behavioral and Neurodevelopmental Disorders	active	2022-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.105.12.1205	Schizophrenia	active	2021-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.105.12.1206	Seizure Disorder	active	2022-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.105.12.1207	REM Sleep Behavior Disorder	active	2021-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.105.12.1208	Benzodiazepine Withdrawal	active	2021-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.105.12.1209	Alcohol Withdrawal	active	2021-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.105.12.1210	Generalized Anxiety Disorder	active	2021-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1050	Potentially Harmful Gastrointestinal Antispasmodics for Older Adults	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1051	Dipyridamole Medications	active	2021-09
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1053	Nifedipine Medications	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1054	Potentially Harmful Antidepressants for Older Adults	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1055	Potentially Harmful Barbiturates for Older Adults	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1057	Meprobamate Medications	active	2021-09
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1058	Potentially Harmful Estrogens for Older Adults	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1059	Potentially Harmful Sulfonylureas for Older Adults	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.106.11.1001	Substance Use Disorder	active	2025-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.106.11.1003	Substance Use Disorder	active	2021-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.106.11.1012	Substance Use Disorder Treatment	active	2021-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.106.11.1036	Substance Use Disorder Treatment	active	2021-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.106.12.1001	Substance Use Disorder	active	2022-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.106.12.1005	Substance Use Disorder Treatment	active	2022-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1060	Desiccated Thyroid Medications	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1062	Potentially Harmful Skeletal Muscle Relaxants for Older Adults	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1063	Potentially Harmful Pain Medications for Older Adults	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1065	Digoxin Medications	active	2021-09
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1066	Digoxin Medications	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1067	Doxepin Medications	active	2021-09
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1068	Doxepin Medications	active	2021-09
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.108.11.1001	Malignant Neoplasm of Colon	active	2024-11
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.108.11.1003	Malignant Neoplasm of Colon	active	2023-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.108.11.1025	Malignant Neoplasm of Lymphatic and Hematopoietic Tissue	active	2024-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.108.11.1027	Malignant Neoplasm of Lymphatic and Hematopoietic Tissue	active	2022-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.108.11.1044	Pap Test	active	2017-05
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.108.11.1047	Mammography	active	2024-11
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.108.11.1051	Colonoscopy	active	2023-11
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.108.11.1052	Colonoscopy	active	2017-12
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.108.11.1053	Colonoscopy	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.108.11.1145	sDNA FIT Test	active	2017-12
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.108.12.1001	Malignant Neoplasm of Colon	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.108.12.1009	Malignant Neoplasm of Lymphatic and Hematopoietic Tissue	active	2022-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.108.12.1017	Pap Test	active	2022-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.108.12.1018	Mammography	active	2022-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.108.12.1020	Colonoscopy	active	2022-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.108.12.1038	CT Colonography	active	2022-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.108.12.1039	sDNA FIT Test	active	2022-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.109.11.1024	Kidney Transplant	active	2021-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.109.11.1025	Kidney Transplant	active	2021-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.109.11.1026	Dialysis Services	active	2021-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.109.11.1027	Dialysis Services	active	2021-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.109.11.1028	Dialysis Services	active	2017-05
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.109.11.1029	ESRD Monthly Outpatient Services	active	2017-08
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.109.11.1052	Kidney Transplant	active	2017-05
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.109.11.1060	Kidney Transplant Recipient	active	2019-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.109.11.1067	Kidney Transplant	active	2019-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.109.12.1012	Kidney Transplant	active	2022-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.109.12.1013	Dialysis Services	active	2022-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.109.12.1014	ESRD Monthly Outpatient Services	active	2017-05
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.109.12.1029	Kidney Transplant Recipient	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1065	DTaP Vaccine Administered	active	2021-09
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1066	DTaP Vaccine Administered	active	2024-11
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1068	Hepatitis A	active	2019-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1070	Hepatitis A	active	2017-05
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1078	Measles	active	2021-09
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1080	Measles	active	2017-05
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1085	Measles, Mumps and Rubella (MMR) Vaccine Administered	active	2017-05
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1086	Measles, Mumps and Rubella (MMR) Vaccine Administered	active	2023-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1087	Mumps	active	2023-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1089	Mumps	active	2017-05
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1098	Rubella	active	2021-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.110	Rubella	active	2017-05
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1104	Varicella Zoster	active	2017-05
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1105	Varicella Zoster	active	2025-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1106	Varicella Zoster Vaccine (VZV) Administered	active	2017-05
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1107	Varicella Zoster Vaccine (VZV) Administered	active	2023-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1109	Hepatitis A Vaccine Administered	active	2017-05
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1110	Hepatitis A Vaccine Administered	active	2024-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1111	Hepatitis B Vaccine Administered	active	2021-09
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1112	Hepatitis B Vaccine Administered	active	2023-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1115	Child Influenza Vaccine Administered	active	2023-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1116	Child Influenza Vaccine Administered	active	2023-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1117	Inactivated Polio Vaccine (IPV) Administered	active	2021-09
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1118	Inactivated Polio Vaccine (IPV) Administered	active	2023-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1119	Pneumococcal Conjugate Vaccine Administered	active	2023-11
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1120	Rotavirus Vaccine (3 dose schedule) Administered	active	2017-05
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1121	Rotavirus Vaccine (2 dose schedule) Administered	active	2017-05
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1123	Genital Herpes	active	2024-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1124	Genital Herpes	active	2024-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1128	Lab Tests for Sexually Transmitted Infections	active	2022-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1129	Chlamydia Screening	active	2024-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1133	Pneumococcal Conjugate Vaccine Administered	active	2024-11
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1135	HPV Test	active	2024-11
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1148	Rotavirus Vaccine (2 Dose Schedule) Administered	active	2019-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1149	Rotavirus Vaccine (3 Dose Schedule) Administered	active	2019-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1150	Advanced Illness	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1151	Advanced Illness	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1152	HiB Vaccine (3 dose schedule)	active	2021-12
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1153	HiB Vaccine (3 dose schedule) Administered	active	2021-09
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1154	HiB Vaccine (4 dose schedule)	active	2021-09
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1155	HiB Vaccine (4 dose schedule) Administered	active	2021-09
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1156	HiB Vaccine (3 dose schedule) Administered	active	2024-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1157	HiB Vaccine (4 dose schedule) Administered	active	2024-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1158	Competing Conditions for Respiratory Conditions	active	2024-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.11.1159	Competing Conditions for Respiratory Conditions	active	2023-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1022	DTaP Vaccine Administered	active	2022-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1024	Hepatitis A	active	2017-05
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1031	Measles, Mumps and Rubella (MMR) Vaccine Administered	active	2022-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1032	Mumps	active	2017-05
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1037	Rubella	active	2017-05
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1039	Varicella Zoster	active	2022-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1040	Varicella Zoster Vaccine (VZV) Administered	active	2022-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1041	Hepatitis A Vaccine Administered	active	2022-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1042	Hepatitis B Vaccine Administered	active	2022-09
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1044	Child Influenza Vaccine Administered	active	2022-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1045	Inactivated Polio Vaccine (IPV) Administered	active	2022-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1046	Pneumococcal Conjugate Vaccine Administered	active	2022-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1047	Rotavirus Vaccine (3 dose schedule) Administered	active	2022-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1048	Rotavirus Vaccine (2 dose schedule) Administered	active	2022-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1049	Genital Herpes	active	2018-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1051	Lab Tests for Sexually Transmitted Infections	active	2022-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1052	Chlamydia Screening	active	2022-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1053	Measles	active	2017-05
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1059	HPV Test	active	2022-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1082	Advanced Illness	active	2022-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1083	Hib Vaccine (3 dose schedule)	active	2019-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1084	Hib Vaccine (3 dose schedule) Administered	active	2022-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1085	Hib Vaccine (4 dose schedule)	active	2019-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1086	Hib Vaccine (4 dose schedule) Administered	active	2022-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1087	Influenza Virus LAIV Vaccine	active	2021-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.110.12.1088	Influenza Virus LAIV Vaccine Administered	active	2021-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.111.11.1012	Lab Tests During Pregnancy	active	2023-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.111.11.1013	Diagnostic Studies During Pregnancy	active	2022-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.111.11.1019	Pregnancy Test	active	2023-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.111.11.1022	Complications of Pregnancy, Childbirth and the Puerperium	active	2024-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.111.11.1023	Complications of Pregnancy, Childbirth and the Puerperium	active	2023-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.111.11.1028	Procedures for Sexual Activity	active	2024-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.111.11.1030	Procedures for Sexual Activity	active	2024-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.111.11.1031	Diagnosis for Sexual Activity	active	2021-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.111.11.1032	Diagnosis for Sexual Activity	active	2024-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.111.11.1033	Procedures for Sexual Activity	active	2021-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.111.12.1007	Lab Tests During Pregnancy	active	2022-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.111.12.1008	Diagnostic Studies During Pregnancy	active	2022-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.111.12.1011	Pregnancy Test	active	2022-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.111.12.1012	Complications of Pregnancy, Childbirth and the Puerperium	active	2022-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.111.12.1016	Congenital or Acquired Absence of Cervix	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.111.12.1017	Procedures Used to Indicate Sexual Activity	active	2022-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.111.12.1018	Diagnoses Used to Indicate Sexual Activity	active	2022-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.112.11.1024	Absence of Cervix	active	2021-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.112.11.1025	Absence of Cervix	active	2021-09
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.112.11.1026	Absence of Cervix	active	2023-09
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.113.11.1073	Osteoporosis Without Current Fracture	active	2017-12
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.113.11.1074	Osteoporosis Without Current Fracture	active	2023-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.113.11.1200	Osteoporosis With Current Fracture	active	2024-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.113.11.1201	Osteoporosis With Current Fracture	active	2024-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.113.11.1202	DXA (Dual energy Xray Absorptiometry) Scan Non Hip or Spine	active	2021-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.113.11.1308	Frailty Diagnosis	active	2024-11
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.113.11.1309	Frailty Diagnosis	active	2025-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.113.11.1310	Frailty Symptom	active	2023-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.113.11.1311	Frailty Symptom	active	2023-11
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.113.12.1038	Osteoporosis Without Current Fracture	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.113.12.1050	Osteoporosis With Current Fracture	active	2018-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.113.12.1051	DXA (Dual energy Xray Absorptiometry) Scan	active	2022-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.113.12.1074	Frailty Diagnosis	active	2019-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.113.12.1075	Frailty Symptom	active	2019-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.114.11.1021	Narcolepsy	active	2018-08
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.114.11.1023	Narcolepsy	active	2017-05
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.114.11.1024	Neurologic impairment	active	2024-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.114.11.1025	Neurologic impairment	active	2017-05
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.114.11.1026	Neurologic impairment	active	2021-09
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.114.12.1011	Narcolepsy	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.114.12.1012	Neurologic impairment	active	2024-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1149	Substance Use Disorder Long Acting Medication	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.115.11.1248	Retinal or Dilated Eye Exam	active	2025-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.115.12.1088	Retinal or Dilated Eye Exam	active	2022-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1150	Substance Use Disorder Short Acting Medication	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1151	Substance Use Disorder Long Acting Medication Administration	active	2025-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1152	Substance Use Disorder Short Acting Medication Administration	active	2024-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1155	Substance Use Disorder Short Acting Medication Administration	active	2023-11
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1156	Substance Use Disorder Long Acting Medication Administration	active	2021-11
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1157	Substance Use Disorder Short Acting Medication Administration	active	2022-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1163	Encephalitis Due to Diphtheria, Tetanus or Pertussis Vaccine	active	2022-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1164	Encephalitis Due to Diphtheria, Tetanus or Pertussis Vaccine	active	2022-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1165	Hospice Diagnosis	active	2022-08
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1166	Hospice Diagnosis	active	2022-08
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1167	Palliative Care Diagnosis	active	2022-08
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1168	Palliative Care Diagnosis	active	2022-08
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1169	Palliative Care Diagnosis	active	2022-08
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.117.11.1031	Hyperthyroidism	active	2018-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.117.11.1033	Hyperthyroidism	active	2018-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.117.11.1034	Hyperparathyroidism	active	2022-02
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.117.11.1036	Hyperparathyroidism	active	2018-03
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.117.12.1015	Hyperthyroidism	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.117.12.1016	Hyperparathyroidism	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1170	Atomoxetine	active	2022-09
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1171	Clonidine	active	2024-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1172	Dexmethylphenidate	active	2025-01
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1173	Dextroamphetamine	active	2022-09
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1174	Lisdexamfetamine	active	2022-09
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.464.1003.1176	Methylphenidate	active	2024-01